
Talde invests in AJL Ophtalmic
Spanish private equity firm Talde, alongside investment firm Kaizaharra Corporación Empresarial (KCE), has backed AJL Ophtalmic, a manufacturer of intraocular implants.
Following the deal, AJL's founder and CEO will stay on with the business as manager and shareholder.
Talde typically invests tickets of €5-15m to acquire majority or qualified minority stakes in Spanish SMEs with enterprise values in the €15-70m range.
Talde and KCE intend to consolidate AJL's market position in the ophthalmology sector, both in Spain and internationally, as well as promote its development in complementary segments of the medical industry.
The company also plans to further invest in its R&D division, which works in partnership with universities, ophthalmologists and medical centres, with the aim of improving its technological innovation and expand its product offering.
Company
Established in 1992 and headquartered in Álava, in the Basque Country, AJL specialises in the design, manufacture and distribution of intraocular lens and implants used in ophthalmology.
The company has production facilities in Alava, Spain, and Chicago, US, and a commercial presence in more than 70 countries worldwide.
People
Talde Private Equity – José María Zalbidegoitia (chair).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds